Epstein-Barr virus (EBV) is a human herpes virus and is etiologically linked to a number of diseases, including multiple sclerosis, infectious mononucleosis, nasopharyngeal carcinoma, Hodgkin's lymphoma, Burkitt's lymphoma and post-transplant lymphoma [1] [2] [3] [4] [5] . EBV belongs to the γ-Herpes virus subfamily and can establish lifelong latency in the host B cells after primary infection, but readily reactivated to produce infectious immortalizing virus in a small percentage of cells 6 . The switch of EBV from latency to lytic cycle is initiated by the expression of the viral immediate-early gene Zta, also known as BZLF1, ZEBRA and EB1 7, 8 . Zta protein is a transcriptional activator that shares partial amino acid homology to a basic leucine zipper family of transcriptional factors, including c-Jun and c-Fos 9 . The Zta gene expression is regulated at the transcriptional level, which alone leads to trigger EBV reactivation cascade 10, 11 . However, the precise molecular mechanism underlying the regulation of Zta gene is largely unknown.
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Extracellular signal-related kinase (ERK) pathway plays an essential role in the regulation of Zta expression and EBV reactivation in response to 12-O-tetradecanoylphorbol-13-acetate (TPA) or other reagents 12, 13 . The c-Jun directly binds on the Zta promoter and activates its activity [14] [15] [16] [17] [18] , and the levels of Zta and phosphorylated c-Jun are much higher in EBV-infected AGS gastric carcinoma cells than in EBV-infected HeLa cells 19 . It is not clearly whether ERK/c-Jun signaling is required for the epigenetic modification, especially DNA demethylation, to trigger Zta expression and EBV reactivation.
DNA methylation in promoter or enhancer regions normally leads to chromatin compaction that serves as a transcriptional silencer to repress gene expression [20] [21] [22] , and conversely, DNA demethylation generates a transcriptional active state. Cytosine 5C position methylation is mediated by several different methyltransferase and usually occurs at CpG dinucleotides 23 . Recent studies indicate that the ten eleven translocation (Tet) family proteins are capable of oxidation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) to erase existing methylation marks by activating DNA demethylation [24] [25] [26] . Furthermore, Tet proteins convert 5mC to Relative protein levels, indicated by numbers below the blots, were determined by densitometry, with internal normalization to β -actin and external normalization to the negative control sample processed in parallel. (d) B95-8 cells were pretreated with U0126 (20 μ M) for 2 h and then treated with TPA (60 ng/ml) for 24 h. The levels of 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) were determined by dot blot analyses. Bulk genomic DNA was isolated, sonicated, cross-linked to nitrocellulose membrane, and probed with the monoclonal antibody specific for 5hmC or 5mC. The loading control is showing by the methylene blue stain in the bottom panel. The blot was quantitated by densitometry, and a representative experiment is shown from three independent experiments. All data were collected from 3 independent experiments. *P < 0.05, **P < 0.01 and ***P < 0.001.
another two important cytosine derivatives, 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC), in an enzymatic activity-dependent manner 27, 28 . 5caC is specifically recognized and excised by thymine-DNA glycosylase and replaced by unmodified cytosine 29 . The EBV genome is heavily methylated in latently infected cells and the constitutive activity of lytic viral genes is repressed by methylation, allowing the virus to establish latency infection 9, 21, [30] [31] [32] . In contrast, the viral genome is hypomethylated during the lytic infection 2, 21, 33 . However, the mechanism of demethylation and the role of Tet in EBV reactivation remain largely unknown.
In this study, we demonstrated that TPA-induced modulation of ERK signaling in conjunction with Tet1-mediated demethylation of Zta promoter dynamically regulate EBV reactivation. ERK-dependent activation of c-Jun results in the recruitment of Tet1 to the Zta promoter to facilitate Zta promoter hypomethylation, Zta gene expression, and eventually EBV reactivation.
Results
ERK/c-Jun pathway is involved in TPA-stimulated demethylation of Zta promoter. The γ-herpes viruses immediate early (IE) gene promoter contains a CpG island within 1kb of the transcription start site, which is highly methylated in many epithelial, NK-and B-cell original cancer cell lines and induced promoter demethylation following treatment with TPA and DNA methyltransferase inhibitor azacytidine 2, [34] [35] [36] . However, the mechanism underlying TPA induces epigenetic modification or DNA demethylation is still unknown. As MAPK/ ERK signal pathway plays an essential role in expression of Zta and EBV reactivation stimulated by TPA 12,13 , we speculated that MAPK/ERK signaling may be involvement in the regulation of DNA demethylation. To verify this speculation, B95-8 cells were pretreated with ERK specific inhibitor U0126 and then with TPA and the methylation status of the Zta promoter was assessed by sodium bisulphite sequencing. The Zta promoter methylation was significantly reduced by TPA (67.06% vs. 15.88%), but TPA-mediated repression was largely recovered in the presence of U0126 (15.88% vs. 35.88%) (Fig. 1a) , indicating that TPA facilitates Zta promoter demethylation and ERK pathway is involved in such regulation. Furthermore, demethylation was detected within 1 hour after TPA treatment (Fig. S1 ). The Zta mRNA (Fig. 1b) and Zta protein (Fig. 1c) were stimulated by TPA, but TPA-mediated activations were attenuated by U0126, suggesting that TPA stimulates Zta gene expression through ERK pathway. To further validate the effect of ERK on Zta promoter demethylation, we examined the production of 5mC and 5hmC in the presence of TPA and/or U0126. Dot blot analyses indicated that 5mC was reduced by TPA and the reduction was recovered by U0126, whereas 5hmC was enhanced by TPA and the enhancement was repressed by U0126 (Fig. 1d) , implicating that TPA-promoted DNA demethylation is dependent on ERK activation. Taken together, we demonstrated that TPA stimulates Zta promoter demethylation to activate Zta expression through ERK pathway. Ser73 phosphorylation of c-Jun is essential for ERK-dependent activation of Zta. To reveal the mechanism by which ERK signaling stimulates DNA demethylation of Zta promoter, the roles of the downstream targets of ERK in TPA-induced Zta expression was investigated. Since cellular transcription factors including c-Jun and c-Fos are known to activate Zta promoter [14] [15] [16] 18, 19, 37 , we examined the involvement of c-Jun and c-Fos in the demethylation of Zta promoter. B95-8 cells were treated with MAPK/ERK inhibitor U0126 for 2 h and then treated with TPA for different times. Zta protein production was stimulated by TPA at 6 h and maintained at a high level until 24 h, ERK phosphorylation was induced by TPA from 1 h to 12 h, c-Jun phosphorylation was induced by TPA at 1 h and increased in a time-dependent manner, whereas c-Fos phosphorylation was up-regulated by TPA from 3 h to 12 h, however, TPA-induced production of Zta and phosphorylation of ERK, c-Jun, and c-Fos were repressed by U0126 (Fig. 2a) . In addition, Ser73 phosphorylation of c-Jun was stimulated rapidly by TPA within 15 min and further facilitated at a higher level at 90 min, but such activation was attenuated by U0126 (Fig. 2b) . Furthermore, Zta mRNA was induced by TPA, before c-Fos phosphorylation and after c-Jun Ser73 phosphorylation, at 1 h post-treatment in a time-dependent manner (Fig. 2c) . These results demonstrated that c-Jun phosphorylation is occurred before Zta expression and suggesting that c-Jun Ser73 phosphorylation is required for Zta expression. c-Jun is required for ERK-dependent DNA demethylation. To confirm the requirement of c-Jun for ERK-dependent DNA demethylation induced by TPA, B95-8 cells were transduced with lentivirus expressing shRNA against c-Jun (shc-Jun) for 2 weeks, selected with puromycin, and then treated with TPA. c-Jun mRNA was attenuated in the presence of shc-Jun (Fig. 3a) , confirming that shc-Jun is effective. In addition, Zta mRNA The cell extracts were prepared and the level of Zta, c-Jun, and β -actin proteins were detected by Western blot analyses (c). The Zta promoter was analyzed by sodium bisulphite sequencing. The white and black circles indicate unmethylated and methylated CpGs, respectively (d). All data were collected from 3 independent experiments. *P < 0.05, **P < 0.01 and ***P < 0.001. (Fig. 3b) and Zta protein (Fig. 3c) were activated by TPA, but the activations were attenuated by shc-Jun, suggesting c-Jun is required for TPA-induced expression of Zta. Moreover, the methylation of Zta promoter was down-regulated by TPA (50.59% vs. 37.06%), whereas this reduction was recovered by shc-Jun (37.06% vs. 60.00%) (Fig. 3d) , indicating that c-Jun is involved in TPA-mediated demethylation of Zta promoter. Taken together, we demonstrated that c-Jun is required for the demethylation of Zta promoter induced by TPA.
c-Jun interacts with Tet1 and recruits Tet1 to the Zta promoter. c-Jun is an important transcription factor involved in cell proliferation, transformation, death, somatic cell reprogramming, and lymphoid leukemia [38] [39] [40] [41] . However, there is no evidence to support that c-Jun is directly participated in the modification of methylcytosine. Since we showed that 5hmC level was increased when treated with TPA (Fig. 1d) , we speculated that c-Jun may promote Zta promoter DNA demethylation through recruiting methylcytosine hydroxylation enzymes (Tet-family proteins).
To test this hypothesis, we initially performed yeast two-hybrid analyses to identify the interaction between c-Jun and Tet1 (a hydroxylase that binds to DNA and modulates gene methylation and transcription via hydroxylation of 5-methylcytosine). Likes BD-p53 interacting with AD-T (as a positive control), a positive interaction was identified between BD-c-Jun and AD-Tet1 CD, but positive interaction was not occurred between BD-c-Jun and AD-vector, between BD-vector and AD-Tet1 CD, or between BD-p53 and AD-Lam (Fig. 4a) . To determine whether the interaction of c-Jun with Tet1 is direct, we carried on GST pull-down assays. The results showed that HA-tagged Tet1 CD interacts with GST-c-Jun (Fig. 4b) , confirming that c-Jun could bind directly with Tet1. To further examine the interaction of c-Jun and Tet1, co-immunoprecipitation (co-IP) assays were performed, which revealed that GFP-tagged c-Jun, but not GFP-tagged c-Fos, was immunoprecipitated with HA-tagged Tet1 CD (Fig. 4c) . Flag-tagged c-Jun was co-immunoprecipitated with HA-tagged Tet1 CD (Fig. 4d, left panel) , and reversely HA-tagged Tet1 CD was co-immunoprecipitated with Flag-tagged c-Jun (Fig. 4d, right panel) . In addition, the interaction of endogenous expressed c-Jun with HA-tagged Tet1 CD was detected by co-IP assays in HEK293 cells (Fig. 4e) . We were also able to coimmunoprecipitate endogenous Tet1 and c-Jun from whole-cell extracts using c-Jun specific antibodies from both control and TPA-treated cells (Fig. S2) .
Moreover, immunofluorescence analysis showed that c-Jun was co-localized with HA-Tet1 CD in the nucleus of HEK293 cells (Fig. 4f) .
Finally, to determine whether c-Jun and Tet1 are occupied at coincident Zta promoter in response to TPA stimulation, we performed chromatin immunoprecipitation (ChIP) assays. As shown in Fig. 4g , we observed much more binding of c-Jun to the Zta promoter in response to TPA, more Tet1 was also found to bind to this promoter. Next, we tested whether c-Jun is required for Tet1 binding to the Zta promoter in response to TPA using the Erk signal pathway specific inhibitor U0126 (Fig. 4g) or knocking down c-Jun (Fig. 4h) . Both U0126 pretreatment and c-Jun knockdown resulted, as expected, in reduced c-Jun activation and binding. More importantly, the decrease in c-Jun occupancy at the promoter coincides with a significant reduction of Tet1 binding to Zta (Fig. 4h) , demonstrating that Tet1 is recruited to the Zta promoter in response to TPA depending on c-Jun. Taken together, we demonstrated that c-Jun interacts with Tet1 and recruits Tet1 to the Zta promoter and suggested that ERK/c-Jun signaling is necessary for the binding of Tet1 to TPA-target Zta promoter. (Fig. 5a ), indicating shTet1 is effective. B95-8 cells were then treated with TPA and transfected with shTet1. The results showed that Zta mRNA and Zta protein were stimulated by TPA, but TPA-mediated activations were significantly repressed by shTet1 (Fig. 5b) . The requirement of Tet1 for ERK-dependent demethylation of Zta promoter was then determined. The results revealed that Zta promoter methylation was significantly repressed by TPA (61.18% vs. 32.94%), but TPA-mediated repression was recovered by shTet1 (32.94% vs. 50.59%) (Fig. 5c) . These results demonstrated that Tet1 is required for ERK-dependent Zta promoter DNA demethylation and gene expression.
Tet1 is required for ERK-dependent

c-Jun and Tet1 are essential for ERK-dependent reactivation of EBV. The role of ERK pathway
in the regulation of EBV reactivation was determined. To evaluate the effect of ERK pathway on the regulation of viral lytic gene expression, B95-8 cells were pretreated with U0126 and then treated with TPA for different times. BHRF1 (a key viral lytic early gene) mRNA was stimulated by TPA in a time-dependent manner, but TPA-mediated activation was repressed by U0126 (Fig. 6a) . To determine the role of ERK in the regulation of EBV c-Fos, followed by western blot analysis with anti-GFP antibody. replication, B95-8 cells were pretreated with U0126 and then treated with TPA for 24 h. EBV genomic DNA copy number was activated by TPA in the absence of U0126, but not in the presence of U0126 (Fig. 6b) , suggesting that ERK is required for the reactivation of EBV induced by TPA. White and black circles indicate unmethylated and methylated CpGs, respectively (c). All data were collected from 3 independent experiments. *P < 0.05, **P < 0.01 and ***P < 0.001. for 2 h and then treated with TPA (60 ng/ml) for 18 h. DNA was prepared from treated cells and the level of EBV genomic DNA was determined by qPCR. Values of viral genome copies are normalized to the control DMSO. (c-e) B95-8 cells were transduced with lentiviruses expressing shCtrl or shTet1 for 2 weeks, selected with puromycin, and then treated with TPA for 18 h. The total RNAs were isolated form the cells and the levels of BHRF1 mRNA (c), pg350/220 mRNA (d), and EBV genomic DNA (e) were determined by qPCR. Values are normalized to the control shCtrl. Error bars represent SD from the mean. All data were collected from 3-6 independent experiments. *P < 0.05, **P < 0.01 and ***P < 0.001.
Furthermore, the effects of c-Jun and Tet1 on the expression of BHRF1 and gp350/220 (a key viral lytic late gene) and the replication of EBV were determined by using RNAi approach. B95-8 cells were transduced with lentiviruses expressing shCtrl, shc-Jun, and shTet1 for 2 weeks at puromycin selection and then treated with TPA for 18 h. BHRF1 mRNA (Fig. 6c ) and gp350/220 mRNA (Fig. 6d) were up-regulated by TPA, but such enhancements were down-regulated by shTet1 or shc-Jun, indicating that Tet1 and c-Jun are required for TPA-stimulated activation of viral lytic early gene and lytic late gene. Finally, EBV genomic DNA copy number was stimulated by TPA, but such activation was attenuated by shTet1 or shc-Jun (Fig. 6e) , revealing that Tet1 and c-Jun are required for TPA-stimulated reactivation of EBV. Taken together, we demonstrated that Tet1 and c-Jun are required for ERK-dependent EBV gene expression and reactivation in response to TPA stimulation.
Discussion
Methylation of CpG sites in the vicinity of the herpes virus immediate-early gene promoter usually inhibits gene expression and maintains viral latent infection 35, 42 . In the contrary, DNA demethylation occurs during virus reactivation in vivo or after the treatment with phorbol ester TPA or DNA methyltransferase inhibitor 5-azacytidine in vitro 33, 35, 43 . However, the molecular mechanism underlying in the process of DNA demethylation is not understood. In this report, we document evidence that ERK signal pathway directs DNA demethylation stimulated by TPA. U0126, an ERK signaling pathway specific inhibitor, impedes Zta promoter demethylation. Ser73 phosphorylation of c-Jun, an ERK downstream transcription factor, is required for Zta gene transcription. Expectedly, depletion of c-Jun in B95-8 cells abrogates TPA-stimulated DNA demethylation of Zta promoter. More importantly, we demonstrate for the first time that c-Jun (an important transcription factor in the Activator protein-1 family) interacts with Tet1 (an important DNA modifying enzyme in the Ten-eleven translocation hydroxylase family) and recruits Tet1 to the Zta promoter region, leading to the initiation of Zta promoter DNA demethylation, IE gene expression, followed by lytic early and late gene expression, and ultimately EBV reactivation (Fig. 6f) .
Previous studies have focused on Zta proximal promoter region (− 221 to + 12) and identified many important transcription factor binding elements essential for EBV latency or lytic infection, including c-Jun, ATF1, Sp1/3, MEF2D and ZEB1 15, 18, 19, 37, 44 . Additionally, there is only one CpG site in the proximal section and different sensitivity of cell types to DNA methyltransferase inhibitor [44] [45] [46] , and therefore, the significance of DNA demethylation on regulating Zta gene expression is always undervalued. In this study, we expand the bisulfite genomic sequencing region from − 400 to − 800 where is abundant with CpG sites. We further demonstrated that Zta gene promoter DNA methylation is significantly decreases in respond to TPA stimulation. The incomplete DNA methylation on Zta gene promoter implicates that the low spontaneous lytic level is permitted. Furthermore, Zta protein preferentially binds to and activates the cytosine-methylated silent viral promoters 30, [47] [48] [49] [50] [51] , and also auto-regulates itself promoter 52 , so Zta may replace Tet1 to promote EBV reactivation without any more DNA demethylation. Therefore, we revel that TPA induces DNA demethylation, but TPA can not present a completely unmethylated status on Zta promoter.
c-Jun is a founding member of the activator protein-1 (AP-1) transcription factor family involved in cell proliferation, transformation, apoptosis, carcinogenesis 41, 53, 54 . In p185 BCR-ABL -transformed cells, lack of c-Jun leads to methylation within the 5′ region of cell-cycle kinase 6 gene (Cdk6) and down-regulate the production of CDK6 protein 38 , which implicates that c-Jun may play a key role in maintaining hypomethylation of Cdk6. Recently, the DNA dioxygenase Tet1 has been reported to play an important role in the reprogramming of somatic cells to pluripotency [55] [56] [57] [58] , and c-Jun impedes somatic cell reprogramming 40 . Combination with our finding that c-Jun interacts with Tet1 and recruits Tet1 to Zta gene promoter, it is possible that Tet1 is hijacked by c-Jun to regulate the expression of a subset of key reprogramming target genes. However, the assumption still needs further investigation.
In conclusion, we reveal that the activation of ERK/c-Jun signaling is required for the recruiting of Tet1 to the viral immediate-early gene promoter, which leads to the induction of DNA demethylation and viral reactivation. These results would provide new insights into our understanding the role of ERK signaling in the regulation of epigenetic modification changes and also would provide new insights into the mechanism underlying the regulation of EBV reactivation.
Methods
For details of Methods, see Supplemental Methods.
Plasmids, antibodies, and regents. The plasmid HA-Tet1 CD (pAAV-EF1a-HA-hTet1CD-WPRE-PolyA) was a gift from Hongjun Song (Addgene plasmid # 39454) 25 . We cloned the c-Jun cDNA (isolated from HEK293T cells) into pCMV-Tag 2B (Stratagene) and pGEX-6p-1 (GE Healthcare) vector to create Flag-c-Jun and GST-c-Jun, respectively.
Antibodies against EBV Zta (ZEBRA) (sc-53904, 1:200), c-Jun (sc-1694), c-Fos (sc-52) and ERK (sc-153) were purchased from Santa Cruz Technology Company. Rabbit polyclonal antibodies against p-ERK (p-P44/42 MAPK, # 4370S), p-c-Jun (Ser73, # 3270P) and p-c-Fos (Ser32, # 5348S) were obtained from Cell Signaling Technology. Mouse monoclonal anti-Flag antibody (Cat# F1804) and anti-HA antibody (Cat# H6908) produced in rabbit were purchased from Sigma Aldrich. Polyclonal antibody against Tet1 (Cat# GTX124207) was purchased from Gene Tex. Antibodies against 5-methylcytosine (5mC, MABE146) and 5-Hydroxymethylcytidine (5hmC, Cat# 39769) were obtained from Millipore and Active Motif, respectively.
The TPA (12-O-Tetradecanoylphorbol-13-acetate) (Cat# P8139) and U0126 (Cat# U120) were purchased from Sigma Aldrich.
